Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation

Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation

Background Monitoring of blood coagulation is essential in ECMO patients. We investigated the prevalence of lupus anticoagulant (LA) and its association with coagulation testing and hemostaseologic complications in patients treated with ECMO. Methods This is a retrospective analysis including adult...

Full description

Bibliographic Details
Main Authors: Andrea Kornfehl MD, Roman Brock MD, Thomas Staudinger MD, Peter Schellongowski MD, Bernhard Nagler MD, Alexander Hermann MD, PhD, Oliver Robak MD, Michael Schwameis MD, Peter Quehenberger MD, Nina Buchtele MD, PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-10-01
Series:Clinical and Applied Thrombosis/Hemostasis
Online Access:https://doi.org/10.1177/10760296231207062

Internet

https://doi.org/10.1177/10760296231207062

Similar Items